QuidelOrtho Analyst Price Targets - Benzinga

QuidelOrtho Corp

QDELNASDAQ

Trade with Public

Trade with Public

$16.92

-0.57-3.29%

Last update: Aug 6, 11:53 AM

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

QuidelOrtho Analyst Price Targets

Wall Street analyst price targets and consensus rating for QuidelOrtho (QDEL).

Price Target Range — 13 Quarters

Analyst Consensus — 8 Analysts

3Buy

4Hold

1Sell

Consensus RatingNeutral# Analysts8Avg. Consensus PT$37Upside to Avg. PT+120.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 8, 2026	Citigroup	Patrick Donnelly	PT Raise	Neutral	$13→$18
Jul 1, 2026	JP Morgan	Casey Woodring	PT Raise	Underweight	$11→$12
May 7, 2026	Jefferies	Tycho Peterson	Downgrade	Buy→Hold	$35→$13
May 6, 2026	Citigroup	Patrick Donnelly	PT Cut	Neutral	$30→$13
Apr 10, 2026	UBS	Lu Li	PT Cut	Neutral	$30→$17
Feb 12, 2026	Citigroup	Patrick Donnelly	PT Raise	Neutral	$23→$30
Jan 21, 2026	UBS	Lu Li	PT Raise	Neutral	$31→$35
Nov 7, 2025	JP Morgan	Casey Woodring	PT Cut	Underweight	$26→$22
Nov 6, 2025	UBS	Lu Li	PT Raise	Neutral	$26→$31
Oct 7, 2025	Citigroup	Patrick Donnelly	Downgrade	Buy→Neutral	$40→$33
Aug 7, 2025	UBS	Lu Li	PT Cut	Neutral	$29→$26
Aug 6, 2025	Citigroup	Patrick Donnelly	PT Cut	Buy	$50→$40
May 8, 2025	UBS	Lu Li	PT Cut	Neutral	$45→$29
May 8, 2025	Jefferies	Tycho Peterson	Upgrade	Hold→Buy	$44
Apr 21, 2025	JP Morgan	Casey Woodring	PT Cut	Underweight	$38→$25
Feb 13, 2025	RBC Capital	Conor McNamara	PT Cut	Outperform	$64→$61
Feb 13, 2025	UBS	John Sourbeer	PT Raise	Neutral	$43→$45
Dec 11, 2024	Citigroup	Patrick Donnelly	Upgrade	Neutral→Buy	$44→$50
Dec 10, 2024	Jefferies	Tycho Peterson	Initiate	Hold	$43
Nov 8, 2024	UBS	John Sourbeer	PT Cut	Neutral	$50→$43

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Citigroup Maintains Neutral on QuidelOrtho, Raises Price Target to $18

Citigroup analyst Patrick Donnelly maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and raises the price target from $13 to $18.

Benzinga Newsdesk

PRO
JP Morgan Maintains Underweight on QuidelOrtho, Raises Price Target to $12

JP Morgan analyst Casey Woodring maintains QuidelOrtho (NASDAQ:QDEL) with a Underweight and raises the price target from $11 to $12.

Benzinga Newsdesk

PRO
Jefferies Downgrades QuidelOrtho to Hold, Lowers Price Target to $12.5

Jefferies analyst Tycho Peterson downgrades QuidelOrtho (NASDAQ:QDEL) from Buy to Hold and lowers the price target from $35 to $12.5.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on QuidelOrtho, Lowers Price Target to $13

Citigroup analyst Patrick Donnelly maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and lowers the price target from $30 to $13.

Benzinga Newsdesk

QuidelOrtho Stock Sinks To 52-Week Low - Here's Why

QuidelOrtho (QDEL) stock hits 52-week low as Q1 revenue of $615M-$620M misses targets. China snags and a weak flu season drive 32% decline.

Vandana Singh

PRO
UBS Maintains Neutral on QuidelOrtho, Lowers Price Target to $17

UBS analyst Lu Li maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and lowers the price target from $30 to $17.

Benzinga Newsdesk